SJVN, the company, has signed agreements to buy 300 megawatts (MW) of renewable energy for its projects. The agreements were signed by its fully-owned subsidiary, SJVN Green Energy. The deal includes a 200-MW solar project in Maharashtra and a 100-MW wind power project in Delhi. The costs of developing the Maharashtra and Delhi projects are Rs 1,200 crore and Rs 750 crore, respectively.
Biocon received a Form 483 from the FDA after two inspections at its Malaysia facility. The form contains eight observations from the FDA.
Power Finance Corporation (PFC) has signed a memorandum of understanding (MoU) worth Rs 2.37 lakh crore with 20 companies in the clean energy sector. The MoUs were signed with various companies, including Adani Group, Greenco, ReNew, Continuum, Avaada, JBM Auto, Megha Engineering & Infrastructure, and Rajasthan Renewable Energy.
The company has approved a buyback of 6.65 lakh fully paid-up equity shares, which is 0.72% of the total shares. The buyback price is Rs 900 per share, totaling Rs 59.85 crore. This buyback represents 5.44% of the fully paid-up equity share capital and 5.10% of the free reserves.
The company has appointed Shantanu Roy as the new Chairman and Managing Director, starting from August 1, 2023. He was previously the Director of Mining & Construction Business.
The company's unit, Zomato Media Portugal, Unipessoal Lda, has started the liquidation process. This unit is not a significant subsidiary, and its dissolution won't impact the company's turnover. ZM Portugal is valued at Rs 1.2 crore, which is only 0.01% of Zomato's net worth.
Lupin, the drugmaker, has received tentative approval from the U.S. FDA for Dolutegravir, Lamivudine, and Tenofovir Alafenamide Tablets. This approval is under the U.S. President's Emergency Plan for AIDS Relief. The product will be manufactured at Lupin's facility in Nagpur, India.